IV Ketamine
Sponsors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Dr. Marie Eve Sophie Bussiere-Cote, Tel-Aviv Sourasky Medical Center, Naveen Poonai, Icahn School of Medicine at Mount Sinai
Conditions
Abortion in First TrimesterAcute PainBone FracturesDepressionDislocationDislocationsFractureMajor Depression Disorder
Phase 2
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
RecruitingNCT04195256
Start: 2020-03-11End: 2026-12-31Target: 400Updated: 2024-11-05
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
Active, not recruitingNCT06069843
Start: 2024-11-01End: 2025-09-30Updated: 2025-01-29
Ketamine Treatment for PTSD and MDD in TBI
Not yet recruitingNCT06228391
Start: 2024-03-31End: 2027-03-31Target: 40Updated: 2024-01-29
Phase 3
Intranasal Ketamine for Procedural Sedation
NCT02828566
Start: 2017-10-31End: 2019-02-28Target: 470Updated: 2017-08-29
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
SuspendedNCT03751423
Start: 2019-06-10End: 2023-12-31Target: 123Updated: 2022-09-08
Comparison of Treatment by IM Ketamine to IV Ketamine in Patients With Renal Colic
NCT04013958
Start: 2019-08-01End: 2021-08-01Target: 100Updated: 2019-07-10